Other News

Vivalink Announces World’s First Multi-Vital Blood Pressure Patch for Remote Patient Monitoring

Integrated patch offers ECG, heart rate, respiratory rate, and blood pressure monitoring for commercial research and development Campbell, Calif. – May 3, 2022 – Vivalink, a leading provider of digital healthcare solutions, announces availability of the world’s first multi-vital blood pressure patch for remote patient monitoring for use in commercial […]

Movano Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

American Heart Association consortium advances development of evidence-based health tech solutions PLEASANTON, Calif., May 3, 2022 /PRNewswire/ — Movano, a healthcare solutions company at the intersection of medtech and consumer devices, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building […]

Silk Road Medical Announces FDA Approval of Expanded Indications for the ENROUTE® Transcarotid Stent System

SUNNYVALE, Calif., May 02, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that that the U.S. Food and Drug Administration (FDA) approved expanded indications for the ENROUTE stent to include patients at standard […]

Medtronic announces first enrollment in pivotal trial of patients with moderate, symptomatic aortic stenosis

EXPAND TAVR II Pivotal Trial evaluating the Evolut™ TAVR platform in a new patient population Medtronic today announced the first patient enrollment in the EXPAND TAVR II Pivotal Trial, the first randomized clinical trial evaluating the self-expanding, supra-annular Evolut™ TAVR platform in patients with moderate, symptomatic aortic stenosis (AS), a […]

Xcardia Announces First-In-Human Use of its New Xtractor Device for Cardiac Pacemaker and Defibrillator Lead Extraction Procedures

Announcement Follows FDA 510(k) Clearance of Device REHOVOT, Israel, April 29, 2022 /PRNewswire/ — Today, Xcardia Innovation Ltd., a private medical device company developing innovative cardiac pacemaker and defibrillator technology, announced the first-in-human use of its new Xtractor device in patients undergoing lead extraction procedures. Charles J. Love MD, Director, Cardiac Rhythm Device Services and […]

CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany

MONMOUTH JUNCTION, N.J., May 2, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced that the Company has been awarded a new preferred supplier agreement for CytoSorb® with the Asklepios Group (Asklepios), one of the largest private […]

Milestone Pharmaceuticals Announces Presentation of Data from Phase 3 NODE-302 Study of Etripamil for the Treatment of PSVT

– Patients successfully self-managed PSVT episodes with etripamil which reduced need for ED intervention – – As in other studies, etripamil was well tolerated by patients – – Data to be featured during late breaking session at Heart Rhythm 2022 – MONTREAL and CHARLOTTE, N.C., April 30, 2022 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), […]

Biomerics Announces Image Guided Intervention (IGI) Division

SALT LAKE CITY, May 2, 2022 /PRNewswire/ — Biomerics, a leading vertically integrated contract manufacturer for the attractive interventional device market, announced the creation of a new division, Biomerics Image Guided Intervention (IGI). Biomerics’ IGI Division, headquartered in Salt Lake City, provides advanced image generation and processing technologies to enable real-time minimally invasive […]

VOTIS SUBDERMAL IMAGING TECHNOLOGIES, LTD. ANNOUNCES ENROLLMENT OF FIRST HUMAN SUBJECT IN PILOT FEASIBILITY STUDY OF PEDCHECK™ AT HADASSAH MEDICAL CENTER IN JERUSALEM

JERUSALEM, May 2, 2022 /PRNewswire/ — VOTIS Subdermal Imaging Technologies Ltd. announced today that it has enrolled the first patient in the feasibility study of its PedCheckTM device at Hadassah Medical Center in Jerusalem, Israel. The pilot study, entitled “The Use of Hemodynamic Occlusive Vascular Response (HOVR™) technology to Screen for Peripheral Arterial Disease (PAD)”, is intended to […]

Chiesi acquires pioneering therapeutic monoclonal antibodies portfolio against EMAP II as potential treatment for PAH

New investment will progress treatment of pulmonary arterial hypertension (PAH), a rare condition which causes high blood pressure in the blood vessels that supply the lungs and can lead to heart failure. Current approved medications mainly address the symptoms of this rare condition. This novel approach aims to address the […]